Gritstone bio Investor Relations Material
Latest events
Status Update
Gritstone bio
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Gritstone bio Inc
Access all reports
Gritstone bio Inc. is a biotechnology company that develops immunotherapies aimed at treating cancer and infectious diseases. The company leverages its expertise in genomics, machine learning, and immune system biology to create therapeutic vaccines and antibody-based treatments. Gritstone bio focuses on advancing precision medicine through innovative platforms designed to stimulate the immune system to recognize and combat specific disease targets. The company is headquartered in Emeryville, California, and its shares are listed on the NASDAQ.
Key slides for Gritstone bio Inc
Q1 2024
Gritstone bio Inc
Q1 2024
Gritstone bio Inc
Latest articles
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
GRTS
Country
🇺🇸 United States